caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891873931

Farrah KhanM.D.

Medical OncologyBurlington, VTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Farrah Khan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Curtis Green
Diagnostic Radiology · Burlington, VT
35128
Ryan Walsh
Diagnostic Radiology · Burlington, VT
29135
George Gentchos
Diagnostic Radiology · Brick, NJ
2260
Janusz Kikut
Diagnostic Radiology · Burlington, VT
1858
Kim Dittus
Hematology-Oncology · Madison, WI
14118
Janet Ely
Nurse Practitioner · Burlington, VT
13131
Andrea Hildebrand
Diagnostic Radiology · Burlington, VT
1359
GOODHEALTH P.C.1145
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
218
Unique beneficiaries
—
Total services
458
Distinct HCPCS
5
Medicare payment
$40K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 11 Medical Oncology providers in VT — below median (cohort median 620).
PRESCRIBING · PART D · 2024
Total Rx claims
642
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
21
Brand share
35.2%
Top prescribed drugs
Dexamethasone71 claims
Osimertinib Mesylate55 claims
Ondansetron45 claims
Prochlorperazine Maleate43 claims
Apixaban43 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.